Experimental procedure may help prevent weight gain after GLP-1s
New York Post • • health
Key Points:
- A new study suggests that duodenal mucosal resurfacing (DMR), an experimental outpatient procedure, may help prevent weight regain in patients who stop using GLP-1 medications for weight loss.
- GLP-1 drugs like tirzepatide are effective but often discontinued due to cost, side effects, or reluctance to take medication long-term, with over 75% of users quitting within two years and regaining weight rapidly after stopping.
- The DMR procedure involves using an endoscope to apply targeted heat to the duodenum lining, aiming to "reset" gut metabolic signaling disrupted by poor diets and improve weight maintenance after GLP-1 treatment.
- Preliminary results show patients undergoing DMR regained significantly less weight and reported reduced sweet cravings, with benefits increasing over time and no serious complications reported.
- Researchers plan to refine the procedure and explore its use for maintaining weight loss from other methods, addressing the urgent need to combat obesity, which affects 40% of US adults and is linked to numerous serious health conditions.
